Skip to main content
MIRA
NASDAQ Life Sciences

MIRA Pharmaceuticals Publishes Positive Preclinical Data for Obesity/Nicotine Drug SKNY-1

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.98
Mkt Cap
$42.863M
52W Low
$0.9
52W High
$2.45
52W Position info
8.9% above low
Off High info
60% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MIRA is trading near its 52-week low of $0.9 (8.9% above the low).

Summary

MIRA Pharmaceuticals announced the publication of positive preclinical data for its investigational drug SKNY-1, showing promising results for obesity and nicotine addiction in a peer-reviewed journal.


Key Events · Product Development and Regulatory · MIRA

  • SKNY-1 Preclinical Data Published

    MIRA Pharmaceuticals announced the publication of a peer-reviewed manuscript in the International Journal of Molecular Sciences detailing preclinical findings for SKNY-1, its investigational oral drug candidate for obesity and nicotine addiction.

  • Positive Preclinical Findings

    In a zebrafish model of obesity, SKNY-1 demonstrated dose-dependent reductions in body weight (up to 30%), normalization of lipid levels, reduction of hepatic triglyceride accumulation, and attenuation of compulsive feeding and nicotine-seeking behaviors.

  • Mechanism of Action Detailed

    The publication reports SKNY-1's differential engagement of cannabinoid receptor 1 (CB1) signaling pathways, partial agonist activity at cannabinoid receptor 2 (CB2), and selective in vitro inhibition of monoamine oxidase B (MAO-B).

  • Early Stage Development

    The findings are based on preclinical research, and SKNY-1 has not been approved by the FDA, with its safety and efficacy in humans yet to be established.


Analysis · MIRA · Life Sciences

This filing is important because it provides positive preclinical validation for SKNY-1, a drug candidate targeting significant therapeutic areas like obesity and nicotine addiction. For a small biotech company that recently issued a 'going concern' warning, demonstrating progress and positive data in its pipeline is crucial for future funding and investor confidence. While still early-stage (preclinical), these findings are a necessary step in drug development and could support further clinical trials, offering a potential path to address the company's financial challenges.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MIRA was trading at $0.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $42.9M. The 52-week trading range was $0.90 to $2.45. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MIRA - Latest Insights

MIRA
Nov 16, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.6283
Real-time Price: $0.373 info
Change: -$0.2553 (-41%) info
Market Cap: $15.477M info
MIRA
Oct 28, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5561
Real-time Price: $0.373 info
Change: -$0.1831 (-33%) info
Market Cap: $15.477M info
MIRA
Oct 22, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.681
Real-time Price: $0.373 info
Change: -$0.308 (-45%) info
Market Cap: $15.477M info
MIRA
Sep 17, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.373 info
Change: -$0.3371 (-47%) info
Market Cap: $15.477M info
MIRA
Sep 17, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.373 info
Change: -$0.3371 (-47%) info
Market Cap: $15.477M info